Meredith Kaya
SVP, Investor Relations
Head of Investor Relations
Earnings-call appearances
-
Apellis Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-01-08
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-10-05
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-01-10
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-06-30
Apellis Pharmaceuticals, Inc. (APLS)